Serum levels of circulating ICAM-1 are increased in Hodgkin's disease

Leukemia

Volumn 7, Issue 8, 1993, Pages 1245-1249

  Gruss, Hans Jürgen ^a   Dölken, Gottfried ^a   Brach, Marion A ^b   Mertelsmann, Roland ^a   Herrmann, Friedhelm ^b,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ADULT; ARTICLE; BLOOD LEVEL; CELL INTERACTION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HODGKIN DISEASE; HUMAN; IMMUNOSURVEILLANCE; PRIORITY JOURNAL; REED STERNBERG CELL; SYMPTOM;

ADOLESCENT; ADULT; CELL ADHESION MOLECULES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HODGKIN DISEASE; HUMAN; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MIDDLE AGE; MOLECULAR WEIGHT; NEOPLASM STAGING; RECEPTORS, INTERLEUKIN-2; SOLUBILITY;

EID: 0027293744     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Stauton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988;52:925-933.
2. Mallin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function associated antigen 1 (LFA-1). Cell 1987;51:813-819.
3. Makgoba MW, Sanders ME, Ginther Luce EG, Dustin ML, Springer TA, Clark EA, Mannoni P, Shaw S. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature 1988;331:86-88.
4. Larson RS, Springer TA. Structure and function of leukocyte integrins. Immunol Rev 1990;114:181-217.
5. Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited defect in MAC-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med 1987;38:175-194.
6. Clayberge CJ, Wright A, Medeiros LJ, Koller TD, Link MP, Smith SD, Warnke RA, Krensky AM. Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance. Lancet 1987;ii:533-536.
7. Gregory CD, Murray RJ, Edwards CF, Rickinson AB. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitts lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med 1988;167:1811-1824.
8. Rothlein R, Dustin ML, Marlin SD, Springer TA. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 1986;137:1270-1274.
9. Dustin ML, Springer TA. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 1988;107:321-331.
10. Faull RJ, Russ GR. Adhesion of lymphocytes to stimulated vascular endothelial cells occurs via ICAM-1-dependent and ICAM-1-independent pathways. Transpl Proc 1990;22:2099-2100.
11. Dustin ML, Singer KH, Tuck DT, Springer TA. Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule-1 (ICAM-1). J Exp Med 1988; 167: 1323-1340.
12. Frohman EM, Frohman TC, Dustin ML, Vayuvegula B, Choi B, Gupta A, van den Noort S, Gupta S. Induction of ICAM-1 expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor-alpha and interleukin-1: relevance to intracerbral antigen presentation. J Neuroimunol 1989;23:117-124.
13. Vejlsgaard GL, Ralkiaer E, Avnstorp C, Czajkowski M, Marlin SD, Rothlein R. Kinetics and characterization of intercellular adhesion molecule-1 (IC4M-1) expression on keratinocytes in various inflammatory skin lesions and malignant cutaneous lymphornas. J Am Acad Dermatol 1989;20:782-790.
14. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-254.
15. Pober JS, Gimbrone MA, Lapierre LA, Mendrik DL, Fiers W, Rothlein R, Springer TA. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor and immune interferon. J Immunol 1986;137:1893-1896.
16. Rothlein R, Czajkowski M, O'Neill MM, Marlin SD, Mainolfi E, Meduzzi VJ. Induction of intercellular adhesion molecule-1 on primary and continuous cell lines by pro-inflammatory cytokines. J Immunol 1988;141:1665-1669.
17. Smith CW, Rothlein R, Hughes BJ, Mariscalco MM, Schmalstieg FC, Anderson DC. Recognition of an endothelial determinant for CD18-dependent neutrophil adherence and transendothelial migration. J Clin Invest 1988;82:1746-1756.
18. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC. Cooperative, interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 1989,83:2008-2017.
19. Dougherty GJ, Murdoch S, Hogg N. The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur J Immunol 1987;180:35-40.
20. Boyd AW, Wawryk SO, Burns GF, Fecondo JV. Intercellular adhesion molecule-1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms. Proc Natl Acad Sci USA 1988;85:3095-3099.
21. Merluzzi VJ, Rothlein R, Wood C, Stearns CD, Faanes RB, Last-Barney K. Inhibition of human mixed lymphocyte reactions by monoclonal antibodies to intercellular adhesion molecule-1 (ICAM-1). In: Springer TA, Anderson DC, Rosenthal AS, Rothlein R, eds. Leukocyte adhesion molecules. New York: Springer-Verlag, 1989, pp. 244-263.
22. Simmons D, Makgoba MW, Seed B. ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature 1988;331:624-627.
23. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991;338:83-84.
24. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147:3788-3793.
25. Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α: functional consequences on cell-mediated cytotoxicity. J Immunol 1991;147:4398-4401.
26. Adams DH, Hubscher SG, Shaw J, Rothlein R, Neuberger JM. Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet 1989;2:1122-1124.
27. Potocnik AJ, Kinne R, Menninger H, Zacher J, Emmrich F, Kroczek RA. Expression of activation antigens on T cells in rheumatoid arthritis patients. Scand J Immunol 1990;31:213-224.
28. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247:456-459.
29. Harning R, Mainolfi E, Bystryn J-C, Henn M, Meluzzi VJ, Rothlein R. Serum levels of circulating intercellur adhesion molecule 1 in human malignant melanoma. Cane Res 1991;51:5003-5005.
30. Smith CW, Rothlein R, Hughes BJ, Mariscalco MM, Rudloff HE, Schmalstieg FC, Anderson DC. Recognition of an endothelial determinant for CD18-dependent human neutrophil adherence and transendothelial migration. J Clin Invest 1988;82:1746-1756.
31. Marlin SD, Staunton DE, Springer TA, Stratowa C, Somergruber W, Merluzzi VJ. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature 1990;344:70-72.
32. Springer TA, Dustin ML, Kishimoto TK, Marlin SD. The lymphocyte function-associated LFA-1, CD2 and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol 1987;5:223-252.
33. Davignon D, Martz E, Reynolds T, Kürzinger K, Springer TA. Monoclonal antibody to a novel lymphocyte function-associated antigen (LFA-1): mechanism of blockade of T lymphocyte-mediated killing and effects on other T and B lymphocyte functions. J Immunol 1981;1127:590-599.
34. Johnson JP, Stade BG, Holzmann B, Schwable W, Riethmuller G. De novo expression of intercellularadhesion molecule 1 in melanoma correlates with increased risk for metastasis. Proc Natl Acad Sci USA 1989;86:641-644.
35. Natali P, Nicotra MR, Cavaliere R, Bigotti A, Romano G, Temponi M, Ferrone S. Differential expression of intercellular adhesion molecule 1 in primary and metastatic lesions. Cane Res 1990;50:1271-1278.
36. Kageshita T, Nakamura T, Yamada M, Kuriya N, Arao T, Ferrone S. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions. Cancer Res 1991;51:1726-1732.
37. Vanky F, Wang P, Patarroyo M, Klein E. Expresion of adhesion molecule ICAM-1 and major histocompatability complex class I antigens on human cells is required for their interaction with autologous lymphocytes in vitro. Cane Immunol Immunther 1990;31:19-27.
38. Gause A, Roschansky V, Tschiesch A, Smith K, Hasenclever D, Schmits R, Diehl V, Pfreundschuh M. Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma. Ann Oncol 1991;2:43-47.
39. Burton J, Goldman CK, Rao P, Moos M, Waldmann TA. Association of intercellular adhesion molecule 1 with the multichain high-affinily interleukin 2 receptor. Proc Natl Acad Sci USA 1990;87:7329-7333.
40. Gruss H-J, Brach MA, Drexler HG, Bonifer R, Mertelsmann RH, Herrmann F. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Steinberg cells. Cancer Res 1992;52:3353-3360.
41. Sheibani K, Winberg CD, van de Veld S, Blayney DW, Rappoport H. Distribution of lymphocytes with interleukin-2 receptors (Tac antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas: an immunohistiologic study of 3000 cases. Am J Pathol 1987;127:27-37.
42. Carbonne PP, Kaplan HS, Musshoff K, Smithers DW, Tubiano M. Report of the nomenclature committee. Cancer Res 1971;31:1860-1861.
43. Pfreundschuh M, Löffler M, Rühl U, Hiller E, Gerhartz H, Wilmanns W, Kirchner H, Schoppe W, Petsch S. Barrels H, Pflüger K-H, Teichmann J, Fuchs R, Kühn G, Oertel W, Mertelsmann R, Dölken G, Schalk K-P, Worst P, Wilhelmy M, Gassmann W, Loos U, Hinterberger R, Theml H, Wagner T, Samandari S, Schäfgen W, Preiss J, Schmitz N, Mende W, Mödder B, Schick HJ, Diehl V. Therapy of Hodgkin's lymphomas. Results of the German Hodgkin's Study Group, Onkologie 1988;11:48-52.
44. Gause A, Verpoort K, Roschansky V, Tschiersch A, Hasenclever D, Schmits R, Diehl V, Brosteanu O, Pfreundschuh M. The clinical significance of serum CDS antigen levels in adult patients with Hodgkin's disease. Ann Oncol 1991;2:579-583.
45. Tubiana M, Henry-Amar M, van der Werft-Messing B, Henry J, Abbatucci J, Burgers M, Hayat M, Somers R, Laugier A, Carde P. A multivariate analysis of prognostic factors in early stage Hodgkin's disease, Int J Rad Oncol Biol Phys 1985;11:23-29.
46. Löffler M, Pfreundschuh M, Hasenclever D, Hiller E, Gerhartz H, Wilmanns W, Rohloff R, Rühl U, Kühn G, Fuchs R, Kirchner H, Teichmann J, Schoppe W, Petsch S, Wilhelmy W, Worst P, Pflüger KH, Hecht T, Bartels H, Gassmann W, Krüger G, Schmitz G, Oertel W, Diehl V. Prognostic risk factors in advanced Hodgkin's lymphoma. Blut 1988;56:949-955.
47. Gruss H-J, Dölken G, Brach MA, Mertelsmann R, Hertmann F. The significance of serum levels of soluble 60 kD receptors for tumor necrosis factor in patients with Hodgkin's disease. J Clin Oncol 1993; in press.
48. Dummer R, Nestle F, Schäfer E, Wiede J, Röger J, Hartmann A, Burg G. Influence of soluble interleukin-2 receptors and soluble CDS proteins on natural killer cell activity and clinical course in cutaneoius T-cell lymphoma patients. Arch Dermatol Res 1990;8:557-562.
49. Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson D. Soluble interleukin-2 receptors are released from activated lymphoid cells in vitro. J Immunol 1985;135:3172-3177.